FUTURA MEDICAL PLC (FAMDF:OTCMKTS)
$0.0027 0.0001 (3.8462%)
Analysed FUTURA MEDICAL PLC (FAMDF:OTCMKTS) News Sources
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE
29-06-2026
proactiveinvestors.com
Futura Medical reports 'highly positive' data for female sexual health treatment
30-06-2026
proactiveinvestors.com
Futura to appeal European patent decision
07-07-2026
proactiveinvestors.com
Futura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMI
11-07-2026
proactiveinvestors.com
Futura Medical gets greenlight for stronger product "Eroxon Intense"
31-07-2026
proactiveinvestors.com
Futura Medical advances Eroxon pipeline as it reshapes US commercial strategy
01-09-2026
proactiveinvestors.com
Futura Medical launches formal sale process alongside £1.6m placing
03-09-2026
proactiveinvestors.com
Futura Medical upsizes retail offer after strong investor demand
07-09-2026
proactiveinvestors.com
Futura Medical plans 2027 Eroxon Intense launch after positive test
07-10-2026
proactiveinvestors.com
Futura Medical revises sale timetable as finance director steps down
08-10-2026
proactiveinvestors.com
What is the current price of FUTURA MEDICAL PLC (FAMDF:OTCMKTS)?
The current price of FUTURA MEDICAL PLC (FAMDF:OTCMKTS) is $0.0027.
FUTURA MEDICAL PLC (FAMDF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of FUTURA MEDICAL PLC (FAMDF:OTCMKTS) since the previous trading day is $0.0001.
FUTURA MEDICAL PLC (FAMDF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of FUTURA MEDICAL PLC (FAMDF:OTCMKTS) since the previous trading day is 3.8462%.
What is the most recent average sentiment score for FUTURA MEDICAL PLC (FAMDF:OTCMKTS)?
The most recent average sentiment score for FUTURA MEDICAL PLC (FAMDF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for FUTURA MEDICAL PLC (FAMDF:OTCMKTS)?
The most recent sentiment for FUTURA MEDICAL PLC (FAMDF:OTCMKTS) is .
SEC-8K** Filing Available For FUTURA MEDICAL PLC (FAMDF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.